Latest Research: AAO2019 Part 3 – Getting outside, Rebound and Barriers to Myopia Management
Welcome to the final instalment of myopia content from the American Academy of Optometry 2019 meeting. These updates continue from
Conferences/lectures
Latest Research: AAO2019 Part 2 – We Know What we Don’t Know
Welcome to Part 2 of the updates from the American Academy of Optometry 2019 Meeting. These updates all sprung from
Latest Research: AAO2019 Part 1 – The New Facts, Figures and Futures
The third biannual World Congress of Optometry and meeting of the American Academy of Optometry was held in October 2019
GSLS2020 Update 3: Vision lost and Vision saved by Myopia Control
Risk-to-benefit comparison of myopia control Mark Bullimore (pictured in action above) presented some powerful data on the risk-to-benefit comparison of
GSLS2020 Update 2: The parents, the patients and your practice
Welcome to Part 2 of the news update of the 2020 Global Specialty Lens Symposium, held in Las Vegas. Read
GSLS2020 Update 1: Teens, Treatments and Treatment zones
Hello from Las Vegas!! Welcome to the exciting news updates from the Global Specialty Lens Symposium 2020, held January 22-25th.
Latest research: ARVO 2018 – Part 1
The annual Association for Research in Vision and Ophthalmology (ARVO) conference moved off mainland America to Hawaii for the first time in May 2018.
Latest research: ARVO 2018 – Part 2
With over 10,000 attendees and thousands of research posters, papers and symposiums presented over 5 days, it was a mind blowing nerdy extravaganza. Here are a bunch of cutting edge research pieces which I posted to the Myopia Profile Facebook group at the time.
Latest research: ARVO 2018 – Part 3
Discover the latest research from the annual Association for Research in Vision and Ophthalmology (ARVO) conference. Find our more in our part 3 article.
Latest research: International Myopia Conference 2017, Part 1
The session topics covered prevalence, progression and risk factors of myopia, mechanisms such as light exposure and visual pathways, optical and pharmacological methods of myopia control, genetics, clinical trial considerations, myopic eye shape and accommodation and binocularity.
